BioVie Inc. has entered into an agreement to sell up to 4,443,000 shares of its Class A common stock at $1.50 per share, aiming to raise approximately $6.66 million, along with issuing warrants for additional shares. The offering is expected to close on October 22, 2024, and includes a private placement with unregistered warrants exercisable at $1.37 per share.